Biomaterial Database

[Clinical experiences with Ketalar used for evoked response audiometry in children (author's transl)]. 1981

E Reroń, and L Popielski

UI	MeSH Term	Description	Entries
D007223	Infant	A child between 1 and 23 months of age.	Infants
D007649	Ketamine	A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.	2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI-581,Calipsol,Calypsol,Kalipsol,Ketalar,Ketamine Hydrochloride,Ketanest,Ketaset,CI 581,CI581
D008607	Intellectual Disability	Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)	Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D006311	Hearing Disorders	Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.	Distorted Hearing,Dysacusis,Paracousis,Paracusis,Hearing Disorder,Hearing, Distorted
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001039	Aphasia, Broca	An aphasia characterized by impairment of expressive LANGUAGE (speech, writing, signs) and relative preservation of receptive language abilities (i.e., comprehension). This condition is caused by lesions of the motor association cortex in the FRONTAL LOBE (BROCA AREA and adjacent cortical and white matter regions).	Agrammatism,Aphasia, Motor,Aphasia, Nonfluent,Broca Aphasia,Dysphasia, Broca,Agrammatic Broca Aphasia,Agrammatic Broca's Aphasia,Aphasia, Anterior,Aphasia, Ataxic,Aphasia, Expressive,Aphasia, Frontocortical,Dysphasia, Broca's,Verbal Aphasia Syndrome,Agrammatic Broca Aphasias,Agrammatic Broca's Aphasias,Agrammatic Brocas Aphasia,Anterior Aphasia,Anterior Aphasias,Aphasia Syndrome, Verbal,Aphasia Syndromes, Verbal,Aphasia, Agrammatic Broca,Aphasia, Agrammatic Broca's,Aphasias, Agrammatic Broca,Aphasias, Agrammatic Broca's,Aphasias, Anterior,Aphasias, Ataxic,Aphasias, Broca,Aphasias, Frontocortical,Ataxic Aphasia,Ataxic Aphasias,Broca Aphasia, Agrammatic,Broca Aphasias,Broca Aphasias, Agrammatic,Broca Dysphasia,Broca's Aphasia, Agrammatic,Broca's Aphasias, Agrammatic,Broca's Dysphasia,Dysphasia, Brocas,Expressive Aphasia,Frontocortical Aphasia,Frontocortical Aphasias,Motor Aphasia,Nonfluent Aphasia,Syndrome, Verbal Aphasia,Syndromes, Verbal Aphasia,Verbal Aphasia Syndromes
D001299	Audiometry	The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds.	Audiometries